- Home
- EVOK vs SBFM Comparison
EVOK vs SBFM Comparison
Compare EVOK & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- SBFM
- Stock Information
- Founded
- EVOK 2007
- SBFM 2006
- Country
- EVOK United States
- SBFM United States
- Employees
- EVOK N/A
- SBFM N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- EVOK Health Care
- SBFM Health Care
- Exchange
- EVOK Nasdaq
- SBFM Nasdaq
- Market Cap
- EVOK 5.4M
- SBFM 6.5M
- IPO Year
- EVOK 2013
- SBFM N/A
- Fundamental
- Price
- EVOK $5.53
- SBFM $1.40
- Analyst Decision
- EVOK
- SBFM Strong Buy
- Analyst Count
- EVOK 0
- SBFM 1
- Target Price
- EVOK N/A
- SBFM $15.00
- AVG Volume (30 Days)
- EVOK 476.4K
- SBFM 41.6K
- Earning Date
- EVOK 08-14-2025
- SBFM 08-12-2025
- Dividend Yield
- EVOK N/A
- SBFM N/A
- EPS Growth
- EVOK N/A
- SBFM N/A
- EPS
- EVOK N/A
- SBFM N/A
- Revenue
- EVOK $12,794,859.00
- SBFM $36,341,741.00
- Revenue This Year
- EVOK $57.82
- SBFM $32.20
- Revenue Next Year
- EVOK $59.12
- SBFM $32.74
- P/E Ratio
- EVOK N/A
- SBFM N/A
- Revenue Growth
- EVOK 70.02
- SBFM 19.22
- 52 Week Low
- EVOK $1.94
- SBFM $1.17
- 52 Week High
- EVOK $12.32
- SBFM $3.90
- Technical
- Relative Strength Index (RSI)
- EVOK 54.74
- SBFM 41.45
- Support Level
- EVOK $4.61
- SBFM $1.36
- Resistance Level
- EVOK $7.04
- SBFM $1.52
- Average True Range (ATR)
- EVOK 0.49
- SBFM 0.07
- MACD
- EVOK 0.03
- SBFM -0.00
- Stochastic Oscillator
- EVOK 37.86
- SBFM 25.00
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.